Janik JE - Search Results

1

Progress on new vaccine strategies for the immunotherapy and prevention of cancer.

Berzofsky JA, Terabe M, Oh S, Belyakov IM, Ahlers JD, Janik JE, Morris JC. Berzofsky JA, et al. Among authors: janik je. J Clin Invest. 2004 Jun;113(11):1515-25. doi: 10.1172/JCI21926. J Clin Invest. 2004. PMID: 15173875 Free PMC article. Review.

2

Progress on new vaccine strategies against chronic viral infections.

Berzofsky JA, Ahlers JD, Janik J, Morris J, Oh S, Terabe M, Belyakov IM. Berzofsky JA, et al. J Clin Invest. 2004 Aug;114(4):450-62. doi: 10.1172/JCI22674. J Clin Invest. 2004. PMID: 15314679 Free PMC article. Review.

3

Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice.

Sakai Y, Morrison BJ, Burke JD, Park JM, Terabe M, Janik JE, Forni G, Berzofsky JA, Morris JC. Sakai Y, et al. Among authors: janik je. Cancer Res. 2004 Nov 1;64(21):8022-8. doi: 10.1158/0008-5472.CAN-03-3442. Cancer Res. 2004. PMID: 15520211

4

A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy.

O'Mahony D, Morris JC, Quinn C, Gao W, Wilson WH, Gause B, Pittaluga S, Neelapu S, Brown M, Fleisher TA, Gulley JL, Schlom J, Nussenblatt R, Albert P, Davis TA, Lowy I, Petrus M, Waldmann TA, Janik JE. O'Mahony D, et al. Among authors: janik je. Clin Cancer Res. 2007 Feb 1;13(3):958-64. doi: 10.1158/1078-0432.CCR-06-1974. Clin Cancer Res. 2007. PMID: 17289891

5

Therapeutic immunotoxins for lymphoid malignancies: the end of the beginning.

Morris JC, Janik JE. Morris JC, et al. Among authors: janik je. Leuk Lymphoma. 2007 Jun;48(6):1067-9. doi: 10.1080/10428190701344949. Leuk Lymphoma. 2007. PMID: 17577767 No abstract available.

6

Receptor-directed therapy of T-cell leukemias and lymphomas.

Morris JC, Waldmann TA, Janik JE. Morris JC, et al. Among authors: janik je. J Immunotoxicol. 2008 Apr;5(2):235-48. doi: 10.1080/15476910802129661. J Immunotoxicol. 2008. PMID: 18569395 Free PMC article. Review.

7

Survivin(g) adult T-cell leukemia/lymphoma.

Janik JE, Morris JC. Janik JE, et al. Oncology (Williston Park). 2009 Dec;23(14):1256, 1261, 1266. Oncology (Williston Park). 2009. PMID: 20120838 Free article. No abstract available.

8

Minimal residual disease detection by flow cytometry in adult T-cell leukemia/lymphoma.

Shao H, Yuan CM, Xi L, Raffeld M, Morris JC, Janik JE, Stetler-Stevenson M. Shao H, et al. Among authors: janik je. Am J Clin Pathol. 2010 Apr;133(4):592-601. doi: 10.1309/AJCPS1K0OHLJYWWV. Am J Clin Pathol. 2010. PMID: 20231613 Free PMC article.

9

Flow cytometric immunophenotypic assessment of T-cell clonality by vβ repertoire analysis in fine-needle aspirates and cerebrospinal fluid.

Tembhare P, Yuan CM, Morris JC, Janik JE, Filie AC, Stetler-Stevenson M. Tembhare P, et al. Among authors: janik je. Am J Clin Pathol. 2012 Feb;137(2):220-6. doi: 10.1309/AJCPPT93VZMAREHK. Am J Clin Pathol. 2012. PMID: 22261447 Free PMC article.

10

Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia.

Chen J, Petrus M, Bamford R, Shih JH, Morris JC, Janik JE, Waldmann TA. Chen J, et al. Among authors: janik je. Blood. 2012 Jan 5;119(1):137-43. doi: 10.1182/blood-2011-04-346759. Epub 2011 Nov 2. Blood. 2012. PMID: 22049515 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters